Granite Investment Partners’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-338,701
| Closed | -$13.5M | – | 315 |
|
|
2017
Q4 | $13.5M | Sell |
338,701
-32,453
| -9% | -$1.29M | 0.85% | 40 |
|
|
2017
Q3 | $14.8M | Sell |
371,154
-111,808
| -23% | -$4.47M | 0.92% | 36 |
|
|
2017
Q2 | $20.8M | Buy |
482,962
+12,163
| +3% | +$524K | 1.4% | 5 |
|
|
2017
Q1 | $14.7M | Buy |
470,799
+43,967
| +10% | +$1.38M | 1.01% | 17 |
|
|
2016
Q4 | $10.8M | Sell |
426,832
-13,939
| -3% | -$352K | 0.79% | 42 |
|
|
2016
Q3 | $10.9M | Sell |
440,771
-86,399
| -16% | -$2.14M | 0.81% | 28 |
|
|
2016
Q2 | $10.7M | Buy |
527,170
+187,670
| +55% | +$3.82M | 0.85% | 31 |
|
|
2016
Q1 | $5.18M | Buy |
339,500
+272,923
| +410% | +$4.16M | 0.47% | 89 |
|
|
2015
Q4 | $895K | Sell |
66,577
-7,157
| -10% | -$96.2K | 0.08% | 236 |
|
|
2015
Q3 | $1.03M | Sell |
73,734
-33,573
| -31% | -$471K | 0.1% | 218 |
|
|
2015
Q2 | $1.82M | Sell |
107,307
-27,089
| -20% | -$460K | 0.17% | 159 |
|
|
2015
Q1 | $1.63M | Buy |
134,396
+35,230
| +36% | +$426K | 0.14% | 179 |
|
|
2014
Q4 | $823K | Buy |
99,166
+58,275
| +143% | +$484K | 0.09% | 241 |
|
|
2014
Q3 | $355K | Buy |
40,891
+1,085
| +3% | +$9.42K | 0.05% | 249 |
|
|
2014
Q2 | $436K | Buy |
39,806
+539
| +1% | +$5.9K | 0.06% | 221 |
|
|
2014
Q1 | $351K | Buy |
+39,267
| New | +$351K | 0.05% | 206 |
|